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Background: Aging and menopause are particular cardiovascular risk factors for women, due to estrogen
deprivation at the time of menopause. Studies show that diabetes mellitus (DM), smoking, hypertension, high body
mass index (BMI), and serum lipids are associated with increased risk of cardiovascular disease (CVD), the main
cause of female mortality in Brazil. The aim of this study was to assess the mortality rate, causes of death and
associated risk factors in a cohort of women from Brazil.
Methods: A longitudinal population-based study of menopausal status is currently underway in a city in South
Brazil. In 2010, a third follow-up of this population was performed to assess cardiovascular risk and mortality rate
between 1995 and 2011. For this analysis, 358 participants were studied. At baseline, participants had completed a
standardized questionnaire including demographic, lifestyle, medical and reproductive characteristics. In addition to
the contacts with relatives, mortality data were obtained through review of medical records in all city hospitals and
the Center for Health Information (NIS/RS-SES). Multivariate-adjusted hazard risk (HR) and 95% confidence intervals
(CI95%) were estimated using Cox proportional hazards regression. Survival curves were estimated using the
Kaplan-Meier curve.
Results: There were 17 (4.7%) deaths from all causes during the study period. Seven (41.2%) deaths were caused by
CVD, including four cases of stroke and three cases of myocardial infarction. Six (35.3%) deaths were due to cancer,
and four (23.5%) were due to other reasons. In the age and smoking-adjusted multivariate models, diabetes (HR
6.645, 95% CI: 1.938–22.79, p = 0.003), alcohol intake (HR 1.228, 95% CI: 1.014-1.487, p = 0.035) and postmenopausal
status (HR = 6.216, 95% CI: 0.963–40.143, p = 0.055) were associated with all-cause mortality. A significant association
was found between abdominal obesity (WHR ≥ 0.85) and mortality even after the adjustment for BMI (HR = 9.229,
95% IC: 2.083–41.504, p = 0.003).
Conclusion: CVD was an important cause of mortality in this cohort and DM and/or central adiposity were
associated with all-cause mortality. Lifestyle and dietary factors seem to be related to risk of mortality in
middle-aged women.
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Life expectancy is increasing in the world as well as in
Brazil, where recent data from the National Geography
and Statistics Institute [1] show that females and males
are now expected to reach 77.3 and 69.7 years of age re-
spectively, as compared to 72.9 and 65.1 years only a
decade ago. This population aging process will have an
impact on health and social policies. However, only a
few studies are available about middle-aged female mor-
tality, especially in Brazil [2,3], where a vast territory and
socioeconomic diversity contribute to a scenario of pub-
lic health inequity. Cultural and economic differences
may influence diet, health, and behavioral factors and
consequently mortality rates. Thus, knowledge of the
pattern of mortality risk is useful to support actions of
prevention and control.
Aging and menopause may be considered as particular
cardiovascular risk factors for women, due to estrogen
deprivation at the time of menopause [4]. Also, studies
have consistently shown that diabetes mellitus (DM)
[5,6], smoking [7,8], hypertension [9,10], high body mass
index (BMI) [11-13] and serum lipids [14] are associated
with increased CVD risk. Therefore, even though CVD
mortality has decreased in recent decades [15,16] follow-
ing improvements in prevention, diagnosis, and timing
of treatment [17], along with gradual improvement in
economic conditions, more widespread access to drugs
[18], heath surveillance, and policies of health promotion
[15], CVD remains a major cause of death [15], and the
main cause of female mortality in Brazil [15,17,19].
Based on these data, and on the scarcity of literature
about this subject, the present study aims to assess mor-
tality, CVD risk factors and causes of death in a cohort




Participants were selected from the population-based co-
hort of the longitudinal menopause study that has been
underway in the city of Passo Fundo, South Brazil, since
1995 [20,21]. As part of this project, an initial cross-
sectional study was performed between 1995 and 1997
to investigate ovarian volume in pre- and perimeno-
pausal women. Sampling was carried out in two stages.
First, 154 census sections (geographical subdivisions of
the city defined by the Brazilian Institute of Geography
and Statistics) were randomly selected. One block in
each census section was picked by lot; two women were
interviewed in each block after the randomization
method described previously [20,21]. A representative
sample of 298 women aged 35 to 55 years who had men-
struated at least once in the past 12 months was ran-
domly identified.In the second field visit, conducted between 2001 and
2002, 239 women from the baseline cohort were located
and interviewed. In view of potential losses to follow-up
and of the increasing city population, 119 additional
women aged 35 to 62 years were sampled to guarantee
enough statistical power for the analysis. The final sam-
ple was 358 women. The samples were selected at ran-
dom based on the first census sections [22] (Figure 1).
Mortality, causes of death, and CVD risk factors
In 2010, a third follow-up was initiated in order to assess
cardiovascular risk and mortality rate. All 358 partici-
pants or their relatives were reached, and information
regarding participant deaths was obtained for the period
ending in November 2011. In addition to the interviews,
the medical records of city hospitals and the Center for
Health Information (NIS/RS-SES) were reviewed. All
deaths between 1995 and 2011 were included in this
analysis.
Medical records were reviewed to collect information
on age at death, date, and cause of death. The causes of
death were coded using the International Classification
of Diseases, 10th revision [23]. Deaths were analyzed for
all-cause and cardiovascular causes (ICD-10: I00-I99),
neoplasms (ICD-10: C00-C97), and respiratory causes
(ICD-10: J00-J99).
Ethics approval for the study was granted by the Research
Ethics Committees at the University of Passo Fundo and
the São Vicente de Paulo Hospital. All study participants
signed an informed consent.
Social characteristics
The participants were interviewed using a pretested stan-
dardized questionnaire covering demographic characteris-
tics (age and self-reported race) and education (years of
successful formal education, described as years at school).
Skin color was classified according to self-report [21,22].
Women were classified in terms of alcohol consumption
as nondrinkers, social drinkers (1 to 15 g alcohol/day), or
abusers (at least 15 g alcohol/day) [24]. Smoking status
was categorized as current, ex-smoker, or nonsmoker [22].
Physical activity was investigated through a previously
tested standardized questionnaire [25]; for each type of
physical activity, the metabolic equivalent [26] and
overall calorie expenditure were calculated. Women
who expended at least 1000 kcal/week (approximately
3.5 hours per week walking, climbing stairs, swimming,
playing sports, doing yard work, and so forth) were
considered to be physically active, whereas the others
were classified as sedentary [22].
Women were classified according to their baseline
menopausal status: premenopause was defined as no
change in menstrual frequency or flow; perimenopause














302 randomized women 
4 missing
Figure 1 Flowchart of the process of study selection and lost to follow-up in the three phases of the study.
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was defined as 12 months or more of amenorrhea, in-
cluding as a result of medical interventions such as bilat-
eral oophorectomy [21,22]. A “hysterectomy” category
was created for women who had undergone hysterec-
tomy and whose menopausal status could not be classi-
fied [27].
The use of hormone therapy (HT), estrogen, estrogen
plus progestogen or tibolone was verified by asking the
women to show the medication box or the physician’s
prescription [21,22].
Anthropometric measurements
Body weight and height was assessed at the beginning of
the study in 1995. Weight (kg) was measured to the
nearest 100 g using a Filizola® scale, Model 31 (Ind
Filizola-SA, São Paulo, Brazil), and height (cm) was mea-
sured to the nearest 0.1 cm with a wall-mounted fixed
stadiometer. Special attention was taken to ensure that
the participants were positioned with the Frankfort plane
[28] horizontal and that they were barefoot. These were
used to calculate BMI, dividing weight in kilograms by
height squared (m2), and categorized as <25.0, 25.0–
29.9, and ≥30.0 kg/m2 [29].
Other anthropometric measurements were made in
duplicate between 2001 and 2003, including waist cir-
cumference (WC) (measured at the midpoint between
the lower rib margin and the iliac crest, perpendicularly
to the long axis of the body, with the participant stand-
ing balanced on both feet, spread approximately 20 cm
apart, with arms hanging freely), hip circumference (wid-
est circumference over the buttocks), and waist to hipratio (WHR) (waist circumference divided by hip cir-
cumference) [21,22,28]. All procedures followed stan-
dardized recommendations [30] and the equipment was
periodically calibrated.
Clinical variables
Previous diagnosis of DM was verified based on phys-
ician report or current use of anti-diabetic medication.
Self-report of hypercholesterolemia or use of anti-
cholesterol medication was used to define dyslipidemia.
Blood pressure was measured after a 10-minute rest.
The same calibrated mercury manometer attached to a
12.5 × 23 cm inflatable cuff was used in all participants,
and the fifth Korotkoff sound was adopted to determine
diastolic pressure. Hypertension was defined as sys-
tolic blood pressure ≥140 and/or diastolic blood pres-
sure ≥90 mmHg or current use of antihypertensive
medication [31,32].
All participants were submitted, in 2003, to blood
sampling between 8 and 10 a.m. after an overnight fast
of 10 to 12 hours. Total cholesterol, high-density choles-
terol (HDL-c), triglycerides, and glucose levels were de-
termined by a colorimetric-enzymatic method (Architect
C800, ABBOTT Systems). Low density lipoprotein chol-
esterol (LDL-c) was determined indirectly using the fol-
lowing formula: LDL-c = total cholesterol - (HDL-c +
triglycerides/5) [33,34].
Statistical analyses
Continuous variables are reported as means ± SDs. Cat-
egorical variables are reported as frequencies (%). Differ-
ences in baseline clinical characteristics between groups
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ables with normal distribution), Mann-Whitney’s U test
(for continuous variables with skewed distribution), or χ2
test (for categorical variables). Survival time for each
participant was defined as the time between the date of
study entry and the occurrence of death. Univariate pre-
dictors of mortality during follow-up were analyzed by
Cox regression models and calculation of hazard rate ra-
tios with 95% CI. For the estimation of hazard ratios, a
Cox regression model was fit including relevant inde-
pendent variables to estimate the associations between
baseline characteristics and mortality. Multivariate ana-
lysis included only variables with a p-value of 0.05 or
lower on univariate analysis. Adjusted hazard ratios
(HR) and 95% confidence intervals (CI95%) for mortality
were estimated. We calculated adjusted hazard ratios
after multivariate correction for age and smoking. The
final model included all variables with P < 0.05 or ac-
cording to clinical plausibility. Collinearity for the model
variables was evaluated using variance inflation factors
and tolerances. No collinearity was found. Survival curves
were estimated using the Kaplan-Meyer method. Log-rank
p-values were calculated to test for significant differences
between mortality and DM. All statistics analyses wereTable 1 Demographic characteristics of participants at baselin
Characteristic Overall group
(n = 358)
Age (years) 44.29 ± 6.01
White skin color (yes) 86.3



















aContinuous variables were compared using the Student’s t-test and expressed as m
using Pearson’s chi-square test and expresses as percentage.performed using SPSS 20.0 software. P < 0.05 was consid-
ered statistically significant for all analyses.
Results
Baseline characteristics
A total of 358 women were studied during a mean follow-
up of 13.4 ± 3.3 years. Table 1 shows the distribution of
baseline characteristics in survivors and non-survivors.
The mean age of the overall sample was 44.29 ± 6.0 years.
Most participants were white (86.3%), with low levels of
schooling (8.4 ± 4.7 years). Considering menopause status,
162 (47.1%) were premenopausal, 134 (39%) were peri-
menopausal, 37 (10.3%) were postmenopausal, and 11
(3.2%) had undergone a hysterectomy. Of the 358 individ-
uals included in the study, 177 (49.4%) reported having
hypertension; 56 (15.6%) used HT, and 14 (3.9%) were dia-
betic. Smoking, a well-known risk factor for CVD, was
found in 96 (26.8%) of the overall sample, and in 8 (47.1%)
deceased patients. Survivors were significantly younger
and almost half were premenopausal. They also had
higher education level and fewer cases of previous DM.
Table 2 describes the metabolic profile of participants.
In general, they had low level of physical activity during
their leisure time and showed baseline overweight ande
Survivors Non-survivors pa
(n = 341) (n = 17)
44.13 ± 6.01 48.00 ± 4.48 0.009
87.0 76.5 0.263


















eans ± standard deviation or median (IQ). Categorical variables were compared
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observed, with normal or borderline values. WHR and
HDL-c were significantly different in survivors and non-
survivors.
Causes of death
The mean age at death was 57.8 ± 5.5 years. In the
13 years analyzed, 17 (4.7%), deaths from all causes were
recorded. Among these, seven (41.2%) deaths were
caused by CVD, including four cases of stroke and three
myocardial infarctions. There were six (35.3%) deaths
due to kidney (n = 1), breast (n = 1), lung (n = 2) and
uterine (n = 2) cancer, and four (23.5%) deaths due to
other reasons, such as polytrauma, asthma, and diabetes.
Survival estimates
The survival for the entire cohort in 6, 12 and 15 years
was 98.6%, 96.8% and 94.3%, respectively (Figure 2).
In a univariate analysis (Table 3), older age (HR = 1.141,
95% IC: 1.051-1.239, p = 0.002), menopausal status (post-
menopause HR = 16.738, 95% CI: 3.644-16.895, p < 0.001),Table 2 Anthropometric and metabolic characteristics of part
Characteristic Overall group
(n = 358)








WHR (cm)c 0.83 ± 0.075
≥ 0.85 43.0
WC (cm)c 85.28 ± 12.25 8
≥ 88 38.3
TC (mg/dl)c 200.01 ± 41.64 2
≥ 200 48.0
HDL-c (mg/dl)c 52.45 ± 10.91 5
<50 40.7
LDL-c (mg/dl)c 122.11 ± 35.89 1
≥ 160 14.9
TG (mg/dl)c 114.0 (79.25-157.5) 114.
≥ 150 27.4
GLU(mg/dL)c 79.0 (71.0-86.0) 79
≥ 126 4.5
aContinuous variables were compared using the Student’s t-test and Mann-Whitney’s U
variables were compared using Pearson’s chi-square test and expressed as percentage. b
of plasma glucose; HDL-c: high-density lipoprotein cholesterol; LDL-c: light-density lipopr
equivalent; TC: plasma total cholesterol; TG: triglycerides; WC: waist circumference; WHR:hysterectomy HR = 11.788, 95% CI: 3.644-121.382, p =
0.038), DM (HR = 10.439, 95% CI: 3.367– 32.367, p <
0.001), and WHR ≥ 0.85 (HR = 3.556, 95% CI: 1.253-
10.094, p = 0.017) were associated with a major probability
of death. Years at school was statistically meaningful in
the univariate model (HR = 0.888, 95% CI: 0,792-0.997,
p = 0.044), suggesting a protective association of higher
level of education.
Table 4 presents the results of multivariate analysis
resulting from the Cox regression model, taking into ac-
count the confounding factors (age and smoking). Previ-
ous diagnosis of DM, WHR ≥ 0.85, and postmenopause
status remained the leading risk factors for all cause mor-
tality, similar to those found in the crude analysis and in-
creasing the risk of death. Diabetic women had higher HR
for mortality (HR = 6.645, 95% CI: 1.938-22.79, p = 0.003).
Postmenopausal status tended to be associated with, and
entailed a six-fold increase in, the risk of death (HR =
6.216, IC: 0.963–40.143, p = 0.055). Alcohol intake was an
independent risk factor for mortality (HR = 1.228, 95% CI:
1.014-1.487, p = 0.035). The magnitude of the associationicipants at baseline
Survivors Non-survivors pa
(n = 341) (n = 17)








0.83 ± 0.072 0.90 ± 0.09 <0.001
41.3 76.5 0.004
5.11 ± 12.35 88.73 ± 9.66 0.235
37.6 47.1 0.445
00.70 ± 40.03 198.0 ± 47.68 0.794
47.8 50.0 0.872
2.35 ± 10.54 57.68 ± 9.97 0.049
41.3 25.0 0.190
19.95 ± 39.34 114.50 ± 41.18 0.386
14.6 12.5 0.783
0 (79.25-159.75) 116.5 (73.25-150.5) 0.886
27.5 23.5 0.716
.0 (70.25-86.0) 81.0 (72.5-93.5) 0.258
4.1 12.5 0.114
test and expressed as means ± standard deviation or median (IQ). Categorical
Data from baseline. cData from 2003 interviews. BMI: body mass index; GLU: levels
otein cholesterol; LPA: leisure physical activity in the previous year; MET: metabolic
waist-to-hip ratio.
Figure 2 Kaplan-Meier estimates of survival among women (n = 358).
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became even greater after the adjustment for BMI (HR =
2.974, 95% CI: 1.039 – 8.510, p = 0.042).
Figure 3 shows Kaplan-Meier curves for DM diagnosis.
The results support the findings of the adjusted model,
according to which mortality is increased in the presence
of diabetes.
Discussion
To the best of our knowledge, this is the first Brazilian
population-based study evaluating survival and causes of
death in pre-, peri- and postmenopausal women. This
prospective follow-up study including women in their
middle age indicates that CVD was the main cause of
mortality. In addition, postmenopausal status, DM, and
central adiposity were associated with increased risk of
mortality, independently of age and smoking. The
present results support the findings of two previous
studies investigating Brazilian postmenopausal women
aged 60 to 80 years [2,3].
Coronary heart disease is the leading cause of death in
women aged 60 years or older [35]. In Brazil, diseases of
the circulatory system are a significant cause of mortality
[19]. A study by Schmitt et al. [36] underscores that, be-
tween 1979 and 2004, cardiovascular diseases, neo-
plasms, and ill-defined causes were the main causes of
death in women in Brazil; these results are similar tothose observed in the present study. Therefore, despite
the small number of deaths (4.7%), our study confirms
data from previous studies, supporting the notion that
CVD are the main cause of death in women in Brazil
[15,17,19].
There was an increased risk of mortality in women
with DM, a recognized clinical condition associated with
risk for cardiovascular mortality [6,37,38]. The associ-
ation between DM and CVD has been suggested to be
stronger in women than in men [6,37,39]. Cardiovascu-
lar mortality is 3 to 5 times higher in diabetic compared
to non-diabetic women, and 2 to 3 times higher in dia-
betic vs. non-diabetic men [40]. A relatively larger mor-
tality for women with DM compared with those with
prior CVD would suggest insufficient attention to CVD
prevention in these women [39]. It has been suggested
that physicians have a less aggressive management of
CVD in women that in men, despite the greater cardiac
disability in women [41]. Gender disparities are also evi-
dent both in the clinical presentation as well as misper-
ceptions and barriers to preventive strategies [42].
It has also been suggested that diabetic women have
accelerated atherogenesis. This process is not completely
understood, but it is at least in part related to more se-
vere lipid and lipoprotein abnormalities, particularly ele-
vated levels of triglycerides and reduced levels of HDL-c,
among diabetic women [43,44]. Increased levels of
Table 3 Crude mortality hazard ratio (HR) and 95%
confidence intervals (95% CI) for survival in 358 women
from a South Brazilian cohort between 1995-2010
Predicting factor HR 95% CI p
Age (years) 1.141 1.051-1.239 0.002
Years at school1 0.888 0.792-0.997 0.044
0 – 4 5.240 1.131-24.275 0.034
5 – 8 1.455 0.243-8.709 0.682
9 – 11 1.869 0.312-11.184 0.493
White skin color (yes) 0.424 0.137-1.308 0.135
Menopausal status2
Perimenopause 2.495 0.729 0.145
Postmenopause 16.738 3.644 <0.001
Hysterectomy 11.788 1.145 0.038
Smoker3 (yes) 2.465 0.951-6.389 0.063
Alcohol intake4
Social Drinker 0.536 0.199-1.440 0.216
Abusers 0.977 0.120-7.942 0.983
Alcohol intake (10 g) 1.193 0.983-1.447 0.074
Hypertension (yes) 1.584 0.601-4.176 0.353
Diabetes (yes) 10.439 3.367-32.367 <0.001
Dyslipidemia (yes) 1.828 0.418-7.994 0.423
HT (yes) 2.856 0.996-8.187 0.051
LPA5,a
1000-1999 cal/sem 0.867 0.159-4.737 0.870
<1000 cal/sem 0.520 0.115-2.346 0.395
BMI (kg/m2) 0.978 0.888-1.077 0.649
WHR ≥ 0.85a 3.629 1.278-10.301 0.015
WC ≥ 88 cma 1.021 0.986-1.058 0.236
TC ≥ 200 mg/dLa 1.078 0.404-2.872 0.881
HDL-c <50 mg/dLa 0.472 0.152-1.464 0.194
LDL-c ≥ 160 mg/dLa 0.790 0.179-3.481 0.755
TG ≥ 150 mg/dLa 0.800 0.261-2.453 0.696
GLU ≥ 126 mg/dLa 3.056 0.694-13.460 0.140
1reference: >12 years at school. 2reference: premenopause. 3reference:
nonsmoker. 4reference: nondrinker. 5reference: ≥ 2000 cal/sem. aData from
2003 interviews. P-value significance: ≤0.05. BMI: body mass index; GLU: levels
of plasma glucose; HDL-c: high-density lipoprotein cholesterol; HT: hormonal
therapy; LDL-c: light-density lipoprotein cholesterol; LPA: Leisure physical
activity in the last year; MET: metabolic equivalent; TC: plasma total
cholesterol; TG: triglycerides; WC: waist circumference; WHR: waist-to-hip ratio.
Table 4 Adjusted mortality hazard ratio (HR) and 95%
confidence intervals (95% CI) for survival in 358 women
from a South Brazilian cohort between 1995-2010
Predicting factor HR 95% CI p
Diabetes 6.645 1.938-22.79 0.003
WHR ≥0.85 2.974 1.039-8.510 0.042
Menopausal status
Perimenopause 2.260 0.656-7.784 0.196
Postmenopause 6.216 0.963-40.143 0.055
Hysterectomy 4.257 0.325-55.779 0.270
Alcohol intake (10 g) 1.228 1.014-1.487 0.035
P-value significance: ≤0.05. CI: confidence interval; HR: hazard ratio; WHR:
waist-to-hip ratio.
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smooth muscle hypertrophy, stimulate vasoconstriction,
and activate the renin-angiotensin system. Simulta-
neously, reduced prostacyclin and nitric oxide activity
enhances platelet aggregation and adhesiveness, leading
to endothelial dysfunction. These facts may contribute
to the poorer outcomes in DM [45,46].
Concerning the relationship between BMI and mortal-
ity, an association between these aspects is widelyaccepted [12,47-49]. Even though this association was
not identified in the present study, BMI is believed to be
a surrogate measure of general adiposity. However, BMI
measures do not distinguish between fat mass and lean
mass [50]. Furthermore, changes in lifestyle patterns,
such as reduction of calorie intake and increased phy-
sical activity, reduce body fat and increase muscle mass.
Individuals within the overweight category may be fit
and muscular rather than having excess fat [51], and a
U-shaped relationship has been described, with in-
creased mortality only at the extremes of underweight
and BMI > 45 kg m [49-51]. In addition to this, data
from the MacArthur Successful Aging Study suggest that
WHR is the most suitable measure for risk stratification
of high functioning, especially in older adults [52]. All
these aspects reinforce our findings that measures of
central adiposity are a good indicator of mortality rates.
The influence of HT on the risk of mortality still needs
to be appropriately defined. In our study, univariate ana-
lysis showed a trend toward higher mortality among HT
users, and age probably had an effect on this group. HT
is considered a Class III intervention and is not effective
for secondary CVD prevention in postmenopausal
women [53,54]. The results from the Women’s Health
Initiative study, the Heart and Estrogen/Progestin
Replacement Study, and the Women’s Estrogen for
Stroke Trial indicate that the use of estrogen alone or es-
trogen plus progestin does not prevent, and could actu-
ally increase, the risk of CVD in older postmenopausal
women or in those with established CV disease [54-58].
Conversely, in women younger than 60 years and within
10 years of menopause, estrogen therapy has been asso-
ciated with decreasing risk of mortality [59].
Menopausal status is an important modifier factor in
female mortality [60]. Previous analyses show an associ-
ation of central adiposity with postmenopausal status
[22,61]. Also, when the risks of inactivity were assessed
for DM, metabolic syndrome, and hypertension, stronger
risk has been detected for post- compared to pre- and
Figure 3 Kaplan Meier estimates of survival among women, according to diabetes prevalence (n=358).
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are more prone to central adiposity [62] and develop-
ment of occult DM than premenopausal individuals [60],
and these risk factors are deeply linked to CVD and con-
sequently to mortality.
Even without presenting a significant HR for death in
the crude model, alcohol is a recognized risk factor linked
to mortality. This was observed in the present adjusted
model. A study with data from the Nurses’ Health Study
demonstrates that small to moderate alcohol ingestion is
related to lower mortality [10]. In a meta-analysis, a
J-shaped relation was observed between mortality and al-
cohol intake; and this inverse association rather disap-
peared in women drinking lower doses than men [63]. In
the present study, we found a greater risk of mortality in
drinkers. This may reflect the fact that alcohol intake in-
creases the relative risk of death in the presence of other
pathologies, such as breast cancer [64].
Moreover, our study suggests that women who had
more years in school had a reduction in the risk of
death, as previously reported [65]. This association may
be explained by the fact that women with more years in
school usually seek health care, have more knowledge of
prevention and thus their disease may be detected at an
earlier phase with more successful outcomes. However,
this difference lost significance in the multivariate ana-
lysis, perhaps because of the low number of events.Strengths of this study are the use of a population-
based cohort and a long follow-up period. Conversely,
limitations include the lack of information on duration
and treatment of DM and hypertension. Our analyses
focus on leisure physical activity because it was the only
category of physical activity measure in our 2001-2003
follow-up. This may have led to an underestimation of
the level of physical activity, with misclassification (par-
ticipants who were active in other types of physical ac-
tivity could have a higher metabolic equivalent (MET)
than that which was calculated and this would influence
mortality). It is important to highlight that our sample is
composed of relatively young women, which explains
the low number of events (death).
Conclusions
The present results suggest that CVD was an important
cause of mortality in this cohort, and that DM and/or
central adiposity were associated with all-cause mortality
in a representative sample of middle-aged women from
South Brazil. Lifestyle and dietary factors seem to be
related to risk of mortality in middle-aged women.
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